Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061in Treatment-Naive HCV Infected Adults:A Randomized,Double-Blind,Phase 1bStudy

查看全文 作　　者：Sulkowski M S;Kang M;Matining R;Wyles D;Johnson V A;Morse G D;Amorosa V;Bhattacharya D;Coughlin K;Wong-Staal F;Glesby M J;AIDS Clinical Trials Group A5277Protocol Team 出　　处：《J Infect Dis》索引2014年第209卷第5期,共0页